Lv1
100 积分 2025-04-29 加入
HER2-targeted therapies — a role beyond breast cancer
13天前
已完结
Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models
24天前
已完结
Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody–Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer
27天前
已完结
Development of a novel humanized anti-TSLP monoclonal antibody, QX008N, and exploration of combination therapy of anti-TSLP antibody and anti-IL-4R antibody
1个月前
已完结
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies
1个月前
已完结
Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?
1个月前
已完结
Psoriasis
1个月前
已完结
IL-23 inhibition for chronic inflammatory disease
1个月前
已完结
Interleukin 23 receptor: Expression and regulation in immune cells
1个月前
已完结
The pivotal role of Interleukin-23 in the skin-gut-joint axis
1个月前
已完结
皖公网安备34019202002308
